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Evaluación de impacto de un
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innovación en pymes
Ricardo Monge-González, Juan Antonio Rodríguez-Alvarez and
Juan Carlos Leiva
Administración de Empresas, Instituto Tecnológico de Costa Rica,
Cartago, Costa Rica
Abstract
Purpose – The purpose of this paper is to estimate the impact of one productive development
program (PROPYME) in a developing nation like Costa Rica. This program seeks to increase the
capacity of small and medium-sized firms (SMEs) to innovate.
Design/methodology/approach – Impacts have been estimated assuming that beneficiary firms
are trying to maximize their profits and that PROPYME aims to increase these firms productivity.
The impacts were measured in terms of three result variables real average wages employment demand
and the probability of exporting. A combination of fixed effects and propensity score matching
techniques was used in estimations to correct for any selection bias. The authors worked with panel
data companies treated and untreated for the period 2001-2011.
Findings – PROPYME’s beneficiaries performed better than other firms in terms of labor demand and
their probability of exporting. In addition, the dose and the duration of the effects of the treatment
(timing effects) are important.
Originality/value – The authors study the impact in ways that go beyond the average treatment
effects on the treated (ATT) usually estimated in the existing literature. Specifically, the research
focusses on the identification of the timing or dynamic effects (i.e. how long should we wait to see
results?) and treatment intensity (dosage effects).
Keywords Impact evaluation, Innovation, Financing, Probability of exporting, Labour demand,
R&D, SMEs, Costa Rica
Paper type Research paper
Resumen
Propósito – Se estima el impacto de un programa de desarrollo productivo (Propyme) en un país en
vías de desarrollo como Costa Rica. El Propyme busca incrementar la capacidad innovadora de las
pequeñas y medidas empresas (pymes) costarricenses.
Diseño/metodológico – el impacto se ha estimado y evaluado asumiendo que las pymes beneficiaras
buscan maximizar sus beneficios y que Propyme se enfoca en incrementar la productividad de esas
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y la probabilidad de exportar. Se utilizó una combinación de técnicas de efectos fijos y emparejamiento
en las estimaciones con el fin de prevenir sesgos de selección. Se trabajó con un panel de datos,
incluyendo empresas tratadas (beneficiarias de Propyme) así como no tratadas para el periodo
2001-2011.
Hallazgos – los beneficiarios de Propyme tuvieron mejor desempeño que las restantes empresas en
términos de empleo demandado y su posibilidad de exportar. Adicionalmente los efectos dinámicos
(dosis y duración) de los tratamientos son importantes.
Originalidad y valor – este artículo evalúa el impacto de una forma que va más allá de lo usual en la
literatura por medio de los efectos promedios de los tratamientos sobre los beneficiarios. Esto por
cuanto se enfoca en efectos dinámicos como la duración así como la intensidad.
Palabras clave evaluación de impacto, innovación, financiamiento, probabilidad de exportar,
empleo demandado, I+D, Pymes, Costa Rica
Tipo de papel Trabajo de investigación
Introduction
There is consensus among practitioners, policy makers and academics that innovation
is vital to improve the productivity and performance of enterprises and nations.
Besides, small and medium enterprises (SMEs) play a fundamental role in countries’
economies (ECLAC-OECD, 2012). Thus fostering innovation in the SMEs is clearly a
desirable goal.
Many countries have been interested in undertaking policies that promote
investments in research and development (R&D) and other innovation-related activities
by local firms due to the existence of market failures (Hobday et al., 2012). In this
regard, the literature shows different approaches. One is to design public policies to
subsidize R&D activities through tax credits and the provision of non-reimbursable
funds (Hausmann and Rodrik, 2002; Martin and Scott, 1998). Another approach has
been to design policies that promote greater competition in the market, thereby
generating higher levels of innovation (Baumol, 2002). Finally, a third approach
has been to develop capital markets to encourage private investment in R&D (Martin
and Scott, 1998).
However, this increase in policies aimed at fostering innovation through R&D
activities, has not been matched, in the same magnitude, by actions to measure the
impact (Dolfsma and Seo, 2013).
In a review of recent literature, López and Tan (2010) identified 19 rigorous impact
evaluation studies, ten from high-income countries and nine from developing ones.
Of these, only three were financing programs to promote investments in R&D, or to
stimulate the development and introduction of new products and production processes
in Latin American developing countries, as is the subject discussed in this paper
(Chudnovsky et al., 2006; De Negri et al., 2006; Benavente et al., 2007).
These studies suggest that SME programs are producing tangible impacts on the
short and medium term intermediate outcomes that they are targeting (i.e. innovation
intensity, technology adoption) but it is not clear whether these gains in intermediate
outcomes translate into longer-term improvements in firm performance (sales,
employment and labor productivity).
However, there is a persistent lack of measurements of the impact of government
policies aimed at fostering R&D (Benavente et al., 2012; Padilla-Pérez and
Gaudin, 2014).
This paper aims to contribute to this topic by assessing the impact of PROPYME,
which is a Government Fund to finance R&D activities in SMEs in Costa Rica. We
















































usually estimated in the existing literature. Specifically, the research focusses on the
identification of the timing or dynamic effects (i.e. how long should we wait to see
results?) and treatment intensity (dosage effects).
In short, we attempt to answer the following questions:
(1) What are the impacts of PROPYME on firm performance?
(2) How long should we wait to see results from the intervention?
(3) Are additional doses of treatment necessary?
In sum, our paper provides evidence of positive impacts on longer-term improvements
in firm performance.
The remainder of the paper is structured as follows. The second section presents
a brief literature review. Third section provides basic information on PROPYME
program. Fourth section presents the methodology employed to estimate the impact.
Fifth section continues with a discussion of the findings, and sixth section presents
the conclusion.
Literature review
Many countries have been interested in undertaking policies that promote investments
in research and development (R&D) and other innovation-related activities by local
firms due to the existence of market failures (Hobday et al., 2012). When a firm invests
in R&D and other innovation drivers, it generates knowledge that can be used by other
firms. If a solid structure to enforce intellectual property rights is in place, monetary
investment in R&D activities becomes the price of knowledge, given that those
property rights allow the owner to exclude others from exploiting the new knowledge.
However, even when the legal and institutional framework for intellectual property
protection is in place, the innovator sometimes cannot fully own the benefits of her or
his investment because of the presence of positive externalities due to technological or
knowledge spillovers resulting from the innovation.
The basic idea of technological spillovers is that the effects of innovation by one
firm tend to spill over into the rest of the economy, mainly to other firms that interact
with the innovator (strategic partners, clients, suppliers, and even competitors)
(Spencer, 2008).
This situation occurs when an innovative firm receives private marginal revenues
which are less than its social marginal revenues; when the knowledge generated by the
firm is spilling over into other firms, thus increasing the benefits to society as a whole
beyond a simple increase in the innovating firm’s profits. The only way for the
innovating firm to obtain some part of the social marginal revenue would be to be paid
for the innovation spilling over into other firms.
Another way of viewing knowledge spillovers is simply that the innovating firm
could be facing a private marginal cost for knowledge production that is higher than
the social marginal cost (i.e. the cost that the firm would face if R&D investments were
also undertaken by other firms and thus the firm could also take advantage of
spillovers from other innovators).
While the effects of externalities can be seen as differences between private and
social revenues or as differences between private and social marginal costs, the
outcome is the same: “the innovating firm is investing less in R&D than the socially
optimum amount, which, combined with the convenience for other firms of acquiring














































country]” (Martin and Scott, 1998, p. 5). In order to correct this market failure,
government intervention is justified. The question that arises, therefore, is what type of
intervention (PDP) should be followed?
The classic theoretical argument is that the government should subsidize the private
provision of knowledge either through tax credits on firms’ investment in R&D or
grants to create incentives for the private sector to undertake more innovation
activities. Subsidies of this kind are permitted by the World Trade Organization’s
(WTO) rules, since they are part of the so-called “green box policies.” According to
Hausmann and Rodrik (2002), any government subsidy to increase the payoff
for innovation should be reduced through time to impose discipline in the use of
scarce resources.
In the case of either export-related activities or production for the domestic market,
tax credits for R&D investments are an interesting policy tool that may unfortunately
generate resistance among the governments of developing countries given the costs
that they entail.
Moreover, Martin and Scott (1998) point out that the effectiveness of tax credits may
be limited because they do not benefit startups, but rather apply only to R&D
investments made by already established companies. This is a serious limitation since, as
stated by Monge-González and Hewitt (2008) for the case of Costa Rica, new companies
(startups) introduce new products to the market (innovations) most frequently.
There is evidence that more competition in a market should lead to greater levels of
innovation and R&D investment (Baumol, 2002). Thus, policies that promote
competition could provide incentives for private investment in R&D, since they help to
overcome anti-competitive practices by incumbent firms and promote cooperative R&D
practices. Trade policies are of particular interest to developing countries. Given that
increased foreign competition and a larger variety of goods are made available
to consumers by international trade, this creates additional incentives for firms to
innovate more.
Another public policy to deal with the public nature of knowledge in the particular
case of SMEs has to do with government support for capital market development in
addition to other non-market instruments (i.e. grants and tax credits) (Martin and
Scott, 1998).
These policies by themselves will not be as effective as they could be if they were
accompanied by a policy of promoting the creation of clusters of innovative businesses
in areas in which a country has clear comparative advantages. The effectiveness of any
general policy for the promotion of innovation is weakened by geographic and
economic distance between businesses, as well as the fact that some innovations occur
in such a way as to minimize knowledge spillovers. Isolated policies (such as
subsidizing R&D or research in universities) may therefore produce relatively weak
and diffuse results (Rodríguez-Clare, 2004).
From the previous discussion, it is clear that the government has good arguments to
promote R&D and innovation activities by SMEs because of market failures that
impede optimal resource allocation. The correction of those failures is a necessary
condition for improving the technological capabilities of SMEs.
PROPYME program
In Costa Rica, the idea of supporting investment in the R&D of SMEs originated almost
















































Development (Law 7169) in 1990, created by the Ministry of Science and Technology of
Costa Rica (MICIT). A decade later, in 2000, a new mechanism called Financing of
Technological Management for Industrial Change, or the Grants Fund (FRC) was
created. Its goal was to promote R&D in SMEs (companies with fewer than 100
employees) and enhance management capacities and competitiveness. Then the
transformation of FRC into PROPYME was an important legal and institutional
improvement. According to Law 8262, PROPYME resources come from Costa Rica’s
public budget, are allocated annually by the Incentives Commission at the MICIT, and
are managed by the National Council for Scientific and Technological Research
(CONICIT). Such a mechanism attempts to avoid resource allocation distortions caused
by political influence, corruption, or moral hazard and discretionary management.
The fund can be used to finance the following types of projects:
• technology development;
• innovation and patent creation;
• technology transfer;
• human capital development;
• technological services development; and
• a combination or complementary pool of projects.
The system operated until June 2012 in two stages on a yearly basis (with two
application processes). First, a firm or group of firms submitted a project proposal to
the Incentives Commission, which evaluated it according to standard criteria, including
the type of scientific activity or technological area the firm is involved in, the potential
impact on firm and sector productivity and competitiveness, the firm’s scientific and
technological capacity, the management capacity of the tender, and the probability that
the firm’s requirements may be effectively served by the proposed project. Second,
qualifying projects competed for a joint venture with a certified research unit (RU)[1].
The RUs present their offers for projects that qualified in the first stage. The winning
offers are selected according to quality, capacity, opportunity, and conditions offered
by the RU as well as additional criteria approved by the Incentives Commission.
Once an RU is chosen to undertake a project, PROPYME may finance as much as 80
percent of its total cost with a non-reimbursable grant, while the SME has to finance the
rest of project. The main idea is to induce entrepreneurship and invest more in R&D
(learning what the SME is good at producing), given that the private profit of such
investment falls below social returns (due to externalities). Thanks to recent efforts by
MICIT, the operation of the system has been modified to make it much more flexible,
allowing firms to participate from the beginning with an RU and allowing the
presentation of proposals throughout the year.
An important reform of the PROPYME fund’s operations was made in May 2011,
but this reform did not enter into effect until June 2012, with the publication of the
respective decree in the official Gazette. The first change was to open a window to
receive applications from businesses throughout the year, instead of only once a year.
The second change had to do with the possibility for a business to apply for PROPYME
funds jointly with the RU of its choosing, from the beginning of the process. The third
change implied reducing the time period in which CONICIT decides whether to
approve an application from a business to a maximum of 30 natural days[2]. A fourth














































beneficiaries to participate in preparing the final draft of the agreement with MICIT for
the use of PROPYME resources. Finally, a program was created whereby technological
managers provide support to beneficiary businesses during their application for
PROPYME resources.
The institutional setting is as follows. The MICIT is responsible for PROPYME
policy design and implementation and is directly involved in monitoring and
accountability. The Ministry of Economy, Industry and Commerce (MEIC) serves as a
consultative body and elaborates the general framework. The CONICIT is responsible
for monitoring and accountability issues. Interest groups from the private sector and
research organizations (from both public universities and private centers) frequently
contact PROPYME administrators to propose changes and improvements in
regulatory mechanisms.
The results can be summarized as follows. Between 2003 and 2011, 170 project
proposals were submitted to the MICIT; only 143 were finally approved. Of these 143
approved projects, only 114 were finally funded. These 114 innovation projects were
carried out by 87 SMEs. The largest numbers of projects proposed were related to
technological development, while the largest numbers of projects financed were related
to human capital development. No firm requested funding for projects related to
patents or technology transfers in this period. The total investment was US$1.7 million
during that period, with an average of US$15,067 allocated to each firm (Table I). The
average amount granted to technological development projects was US$27,930.
It is interesting to note that some firms decided not to participate once they had been
informed of the research unit assigned to jointly implement the project with them. This
situation explains the discrepancies in the amounts approved and executed in Figure 1
for the period analyzed. Additionally, even though a project may be approved in a
given year, it may not be implemented in that same year.
Despite the clear limitations found by Monge-González et al. (2010), beneficiary firms
indicate that PROPYME helped them become more competitive. According to these
authors, most of the SMEs that received support from PROPYME were previously
engaged in innovation activities and continued investing in technological


























66 42 32 1,094,863.50 893,773.22 27,930.41 170,131.43 1,129.93
Technological
services
48 45 35 744,241.72 511,079.80 14,602.28 53,490.37 1,422.25
Technology
transfer
− − − − − − −
Patents − − − − − − −
Human capital 50 50 42 156,629.61 128,016.62 3,048.01 14,534.10 807.45
Hybrid
projects
6 6 5 203,650.66 184,769.88 36,953.98 109,543.71 10,687.33
Total 170 143 114 2,199,385.49 1,717,639.52 15,067.01 170,131.43 807.45
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mentioned by beneficiaries was an improvement in the productivity of the firms,
especially in terms of trained human resources and increased product sales. All of these
results are expected to have an impact on the size of these firms (employment), salaries
(due to higher productivity), and exports (increased market opportunities), which is the
object of analysis in this paper.
Methodological approach
The challenge of carrying out an impact evaluation is to be able to compare the firm’s
performance after program intervention to what would have happened if the firm had
not participated in the program (Storey, 2004). Since the hypothetical scenario (not
participating in the program, having made it) cannot actually be seen, the challenge of
impact evaluations consists in identifying a group of firms that are similar to the group
receiving the treatment (program beneficiaries) in all aspects, except for their
participation in the program. Thus, the difference between the average of the variable
performance of treated firms and the average of the variable performance of companies
in the control group would provide a good approximation of program impact.
We followed a quasi-experimental approach, which requires specific data on the
program under consideration, including data on firms affected by the intervention or
participating in the program and data on a control group of similar firms not affected
and/or not participating. A panel of PROPYME treated and untreated companies
between the years 2001 and 2011 was built for this purpose.
Since PROPYME beneficiaries were not randomly selected, the participation or
selection of firms in the treatment and control groups should be based on observable
and unobservable characteristics that can be controlled for (quasi-experimental design).
The technique we used in carrying out the impact evaluations is a combination of
regression methods and propensity score matching (PSM) that explicitly controls for
differences in observable variables between groups and fixed-effects models. It also
uses data from before and after the program (treated and control groups) to account for
certain types of unobserved heterogeneity.
The PSM is a technique that aims to identify companies with similar characteristics
to those treated by the program before the program is executed. To do this, we had to
choose a group of observable variables that give a good characterization of the
companies treated prior to treatment, and search similar values for the same variables
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Figure 1.
PROPYME funds















































in other companies (non-treated). The companies identified in this way made up the
control group. Thus, any difference observed between the performance of the
companies of the treatment group and the control group, after program execution,
would be attributed to the participation of treated enterprises in the program under
evaluation.
The correct selection of the control group is vital because any difference in
performance between the control group and the treatment group, in terms of observed
or unobserved attributes, affects the accuracy of the estimates of the program’s net
impact. For this reason, it is important to explain the selection strategy used to correct
potential selection biases, and thus to be able to claim that the results obtained from the
impact evaluation are actually attributable to the program intervention under analysis.
Strategy for identifying the control group
Since none of the firms in the panel data received PROPYME funds between 2001 and
2003 (because the program did not exist yet), these years are considered the base, or
pre-treatment, years for the purposes of this analysis.
To estimate the impact on SME performance, we combined the PSM[3] method with
the fixed-effects model. While PSM makes it possible to control for selection bias
attributable to observable firm characteristics, the fixed-effects method makes it
possible to control for non-observable attributes which are considered to be fixed over
time (time-invariant firm characteristics) which may have an effect on a firm’s decision
to receive funds from PROPYME or on its performance over time[4].
To select the control group, it is necessary to carry out an analysis of the variables
that characterize all of the firms before they become program beneficiaries (i.e. in 2002).
Since beneficiary firms received funds from PROPYME at different times during
the period studied, when estimating the PSM for the panel data it was necessary
to calculate a dummy variable D, which takes the value 1 if the firm was
a PROPYME beneficiary at least once during the 2004-2011 period, and 0 if it was never
a beneficiary.
PSM estimates the probability of a firm’s participation in PROPYME funds as a
function of a set of observed variables. The first case consists of estimating the
probability of participation as the matching criteria among beneficiary firms
(treatment), and those that are not benefited (control). Given the large number of
variables characterizing the firms, it is necessary to reduce their values for a firm to a
scalar p(x), defined below, in order to make matching possible. As pointed out by Bernal
and Peña (2011), it is important not to either omit any variable or to over-specify the
model. Careful attention must be paid to which variables to include.
The propensity score is defined as the conditional probability that a firm will
become a PROPYME beneficiary, given the values of a set of observed variables X,
which is expressed as:
p xð Þ ¼ P D ¼ 19X ¼ x  ¼ E D9X ¼ x 
where X is a vector of individual characteristics or variables of the firm, and its
environment.
D ¼
1 if the f irm is a benef iciary
0; otherwise
(
Rosenbaum and Rubin (1983) show that given that whether a firm is a beneficiary
















































multi-dimensional vector X, this selection is also random in the region defined by the
scalar p(x). Therefore, the average effect of the treatment PROPYME funds on
beneficiary firms (ATT) may be specified through the equations:
ATT ¼ E Y 1Y 0½  ¼ E E Y 1Y 09p xð Þ
  
And:
E Y 19p xð Þ;D ¼ 1
 E Y 09p xð Þ;D ¼ 0  ¼ E Y 1Y 09p xð Þ 
where Yi is the outcome variable on which the impact of the PROPYME program is
being measured, and the sub-index i indicates the year of observation of the
outcome variable.
The impact of PROPYME may then be estimated as the difference between the
average of the outcome variable for the treatment group (beneficiaries) and that of
the control group in the area of common support (where data display an overlap in the
characteristics of beneficiaries and non-beneficiaries) defined by the PSM.
A problem with the estimation (ATT) is that it does not take into account the
possibility of selection bias due to non-observed variables, complicated by the fact that
the treatment does not occur, according to the panel data, within the same year for all
firms, nor is it continuous once the business starts to be treated. We therefore estimated
the programs’ impact by using the PSM results to define the treatment and control
groups in a way that meets the common support conditions and use the procedure
for the estimation of the impact equations through a regression method using the
fixed-effects approach.
Specification of the models and estimation procedure
To estimate the impact of PROPYME on SME performance, we applied a set of
regression models to one panel data from 2004 to 2011, relating the outcome variable
(wages, employment, or exports) to a set of covariates, including a dummy variable
which measures whether or not the firm was a beneficiary of the program (D) sometime
in that period. For the case of wages and employment, we derived the model
specifications assuming that Costa Rican SMEs display profit-maximizing behavior.
For the cases of real wages and labor demand, the equations to be estimated (1 and
2) were obtained through a profit maximization procedure[5]. The estimation of
Equations (1) and (2) was conducted using ordinary least square (OLS), using both
fixed-effects and propensity score matching (PSM) plus fixed-effects approaches[6]. In
the case of exports, a linear probability model was used to estimate the impact of the
program on the probability that a firm exported sometime between 2004 and 2011
(Equation 3)[7]. In this last case, both fixed-effects and PSM plus fixed-effects
approaches were used.
In short, the three equations we estimated were the following:
wpð Þit ¼ b0þb1 PREMnSEð Þitþb2Ditþb3Dit1þb4Dit2þb5Xitþeit (1)
l it ¼ g0þg1Ditþg2Dit1þg3Dit2þg4Xitþsit (2)














































where (w-p) is the average real wage paid by the firm (in logs), PREM×SE is the salary
premium received by skilled workers, l the number of workers hired by the firm
(in logs), exp a dummy variable equal to one if the firm exported in year t and 0
otherwise, and X the covariates. Each error term in Equations (1)-(3) is a two-component
term, with one component related to an unobserved specific effect of the firm which
does not vary over time (productive sector, managerial capacity, etc.), but which
may have an impact on the outcome variable, and another component which is
purely stochastic.
We estimated another specification of Equation (3) that includes lag values of the
dependent variable. This was done because a firm’s exports in year t are explained by
its export experience in year t-1, t-2 and t-3. Thus, a dynamic linear probability model is
estimated. According to the standard in the literature, we used the fixed-effect
approach in the estimation of this new specification.
In addition to estimating Equations (1)-(3), we explored the timing of the effects and
whether dosage is really important, following Crespi et al. (2011). In doing so and for the
case of timing of effects, we modified the above three equations, substituting another
dummy called D_timing for the impact variable D. This new dummy takes the value of
1 for all the years since the first intervention and 0 otherwise. For the dosage effect, we
substituted another variable called D_dosage for the impact variable D, which takes the
value of 1 for all the years since the first year the firm was treated and until the year
before the second treatment, equal to 2 since the second year the firm was treated and
until the year before the third treatment, and so on, and 0 otherwise. In other words, we
consider the case whereby a firm was a beneficiary in more than one year.
Data
We collected information on the beneficiaries, which we linked with social security and
export data to obtain micro-data on final outcomes (total employment, average wages,
and exports) as well as on industry sector, location, and legal status of the firm. As
appropriate data, they came from various government sources (ministries, social
security, and foreign trade). This allowed us to build the panel of both PROPYME
treated and untreated companies between the years 2001-2011.
Results
Before showing the results of PROPYME impact evaluation, we present the results
from the propensity score matching (PSM) technique used to identify the firms
belonging to the control group, specifically to the common support.
Estimation of the propensity score and construction of the common support
Table II shows the variables that we include in the estimation of the propensity score
for the sample firms as well as the results of the estimation. We estimated the
probability that firms participated in the program between 2004 and 2011 using firm
characteristics between 2001 and 2003, before any of the firms included in the sample
participated in the program.
We use propensity scores estimated through the participation model presented in
Table II to identify firms that did not participate in the program but that have the
closest propensity score values to firms that did participate in the program. Variables
in the participation model include: geographic location (provinces), since most of the
















































firm is legally registered as a commercial legal entity); sector of economic activity, since
most treated firms conduct specific activities; and firm characteristics, such as number
of workers, average wage, and a dummy variable that indicates whether the firm
exported in 2001 (i.e. prior exporting experience).
Note that all of the coefficients included in the equation are significant, except
location and legal status. In addition, the model as a whole is also significant, and
therefore appropriate for the estimation of the probability of a firm − whether in the
treatment group or in the control group − participating in the PROPYME program. To
achieve common support, it is necessary to eliminate the 20 percent of observations
with the lowest density in the participation probability[8].
Figure 2 shows the distribution of the propensity scores after matching for firms.
Ergo, it shows the PSM results for firms in the treatment and control groups previously
selected within the common support.
Variables Coefficients
Firm is located in San José −0.0903 (0.1755)
Firm has a legal status 0.5421 (0.4038)
Manufacturing 0.3117 (0.1817)*
Chemicals −0.5148 (0.3093)*
Firm exported in the year 2001 0.4800 (0.2362)**
Labor growth b/w 2001 and 2003 0.7797 (0.3428)**
Number of employees in 2003 (logs) −0.3488 (0.1942)*
Real salaries in 2003 (logs) 0.2823 (0.1386)**
Salaries growth b/w 2001 and 2003 −0.5016 (0.2466)**
Constant −6.1060 (1.8541)***




Notes: *,**,***Coefficient is statistically significant at the 10, 5, 1 percent levels, respectively; no
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After identifying the firms in the control group − i.e., firms with similar values for the
propensity score − it is necessary to verify that the characteristics of the control group
are equal to the characteristics of those firms that participated in the program (see
Rosenbaum and Rubin, 1983). We do this by analyzing t tests for equality of means in
the treated and non-treated groups before and after matching (t tests are based on a
regression of each variable on the treatment indicator).
Table III shows the balance in the observable variables before and after matching
for the firms in the common support. After matching, it is not possible to reject the null
hypothesis thatstates that − for all the variables simultaneously − differences in mean
between firms in the program and in the control group are 0. Therefore, the treated and
untreated groups − in the sample after the matching procedure − are statistically
comparable based on the observable variables included in the participation model.
PROPYME’s impact on real average wages
As indicated above, for a correct estimation of PROPYME’s impact, both observable
and non-observable variables whose behavior may affect the result variable
must be controlled for, as well as businesses’ participation in the program. Since the
businesses that benefit from PROPYME are SMEs, the sample for the study −
beneficiary and control group businesses − was limited to only businesses that hire up
to 100 workers[9].
Results for real salaries (Equation 1) are presenzted in Table IV. The second column
shows a positive and significant result for the treatment variable Dt (0.0939), which
suggests that participation of businesses in PROPYME has a positive and significant
impact on the real salaries they pay their employees. When the results of the first and
second columns of Table IV are compared, it can be concluded that the wage premium
for differences in employment categories (Prem×SE) is important in explaining the
model, showing a positive and significant coefficient (0.0605).
Variable Sample Treated Control Difference SE t-stat.
Firm is located in San José Unmatched 0.54839 0.58771 −0.03932 0.09062 −0.43
Matched 0.56000 0.44000 0.12000 0.14329 0.84
Firm has a legal status Unmatched 0.96774 0.88156 0.08618 0.05852 1.47
Matched 0.96000 1.00000 −0.04000 0.04000 −1
Macnufacturing Unmatched 0.64516 0.53523 0.10993 0.09161 1.2
Matched 0.60000 0.40000 0.20000 0.14142 1.41
Chemicals Unmatched 0.09677 0.13943 −0.04266 0.06335 −0.67
Matched 0.12000 0.12000 0.00000 0.09381 0
Firm exported in year 2001 Unmatched 0.32258 0.13493 0.18765 0.06407 2.93
Matched 0.20000 0.24000 −0.04000 0.11944 −0.33
Labor growth b/w 2001/2003 Unmatched 0.11153 0.04462 0.06691 0.07373 0.91
Matched 0.07085 0.15280 −0.08195 0.10051 −0.82
No. Employees in 2003 (logs) Unmatched 2.59054 2.28887 0.30167 0.22100 1.37
Matched 2.50592 2.27133 0.23459 0.33340 0.7
Real salaries in 2003 (logs) Unmatched 16.70874 16.26329 0.44545 0.28563 1.56
Matched 16.63403 16.31679 0.31723 0.38450 0.83
Salaries growth b/w 2001/2003 Unmatched 0.25780 0.25768 0.00012 0.09679 0










































































































































































































































































































































































































































































































































































































































































































































































































On the other hand, it is interesting to note in column 3 that the impact of participation in
PROPYME is experienced during the same year that the treatment is implemented, and not
after a delay of one or two years. In addition, when D_timing is replaced by the treatment
variable, and the dynamic effects (non-linear) of participation in PROPYME are analyzed, it
appears that the longer a business receives the treatment, the greater the impact. In fact, the
coefficient associated with D_timing is positive and significant (0.1069).
This result may be suggesting that firms that benefit from PROPYME later
continue on an innovative path, which has a permanent impact on their performance.
However, proving this is beyond the scope of the present study.
Finally, the result related to treatment dosage shown in column 5 (the coefficient
associated with D_dosage is positive and significant, 0.0421) suggests that a firm that
received benefits from PROPYME several times during the period analyzed (2004-2011)
experienced greater real wages for its employees. This result could be due to the fact
that beneficiary businesses may request support from PROPYME for several
innovative activities, which may be considered complementary.
Although the results of the previous section suggest that participation of firms in
PROPYME increased their real wages, it is pertinent to determine whether the
comparison group used is appropriate. It may be concluded from the discussion in
previous sections that common support, that is, the group of firms with similar
probabilities of participating in the program, is much lower than the group of firms
considered in the analysis when only the fixed-effects approach is used.
Therefore, models whose results are summarized in Table IV were estimated again
controlling for fixed effects, but only for common support firms. These new estimations
are considered to be more robust because firms that are not good “clones” of beneficiary
firms are eliminated from the control group, according to the PSM. Table V shows the
results of the impact of PROPYME on real salaries, using the fixed-effects approach
and PSM, as well as testing for the parallel pre-treatment assumption.
In contrast to the results obtained in Table IV, those in Table V do not show any
impact of PROPYME on real wages of beneficiary firms. In other words, none of the
coefficients associated with the various specifications of the treatment variable (D,
D_timing and D_dosage) were positive and significant. Moreover, since all of the
coefficients associated with pre-treatment variables (PD_r; r¼ 1, 2, 3) in column 6 are
not significant, the fixed-effects approach is valid as an estimation procedure in this
case. Thus, it can be concluded that PROPYME does not have any impact on the
average wages of beneficiary firms.
PROPYME’s impact on labor demand
PROPYME’s impact on labor demand (number of workers) according to Equation (2) is
presented in Tables VI and VII. The results in the first of these tables refer to
estimations using only the fixed-effects approach. From the first column of Table VI, it
may be concluded that participation of businesses in PROPYME has a positive and
significant impact on labor demand in beneficiary firms, given that the coefficient
associated with the treatment variable –D − is positive and significant (0.2540).
In column 2, the impact of participation in PROPYME is experienced during the first
year of treatment, as well as one and two years after the treatment (0.2188, 0.0954 and
0.1315). Moreover, when D_timing is replaced by the treatment variable, and the
dynamic effects (non-linear) of participation in PROPYME are analyzed, the coefficient
associated with D_timing is positive and significant (0.4037); i.e., the longer the firm























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In addition, the result of the treatment dosage (D_dosage) shown in column 4 suggests
that the more times a firm has been treated with the PROPYME program during
the period analyzed (2004-2011), the greater the labor demand. In other words,
longer dosages of treatment seem to increase the labor demand of participating
firms (the coefficient associated with D_dosage is positive and significant, 0.1452).
This result could be due to the fact that beneficiary businesses may request
support from PROPYME for several innovative activities that may be
considered complementary.
Table VII presents the results of the impact of PROPYME assistance on labor
demand using only common support firms and controlling for fixed effects.
Once again, these estimations are considered to be stronger because firms which
are not good “clones” of beneficiary firms according to PSM are eliminated from the
control group.
The results in Table VII verify the existence of a positive and significant impact
of PROPYME on labor demand in beneficiary firms. The coefficient associated with
the treatment variable (D) is positive and significant (0.1976 in column 1 and
0.1878 in column 2). Importantly, the impact is only observed during the same year
when the treatment is applied. Thus, the average impact of the program on treated
firms is 0.19.
When the dynamic results of treatment (D_timing) are analyzed, a positive and
significant coefficient is obtained (0.2339), leading us to conclude that the longer the
time a firm is treated, the greater the impact on labor demand. The coefficient
associated with the dosage (D_dosage) is positive and significant (0.0638), allowing us
to claim that successive treatments have more of an impact on firms’ labor demand
than when they receive only one treatment.
Finally, since none of the coefficients associated with pre-treatment variables in
column 5 are significant, the fixed-effects approach is valid as an estimation procedure
in this case. Thus, we can conclude that the labor demand of treated firms is 19 percent
higher than that of firms from the control group.
PROPYME’s impact on the probability of exporting
The results of the impact of PROPYME on the probability of exporting obtained using
equation (3) are shown in Tables VIII and IX. Table VIII shows the results using a
linear probability model using only the fixed-effects approach. A consideration of the
first column of this table shows that the coefficient associated with the treatment
variable (D) is positive and significant (0.0876), which supports the conclusion that
SME participation in the PROPYME program is important for these firms to increase
their exporting probability. In fact, participation in PROPYME increases such a
probability by almost nine percentage points on average for beneficiary firms with
respect to those in the control group.
In addition, participation in PROPYME seems to have an impact on the exporting
probability of beneficiary firms not only in the same year that they receive the
treatment, but as long as two years after the treatment. Indeed, the coefficients
associated with these effects are positive and significant (0.0944 and 0.0688,
respectively), as shown in the second column of Table VIII.
Another interesting result of this analysis is that the longer a firm has been treated,
the greater the impact on the probability of it exporting. The coefficient associated





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table VIII is positive and significant (0.0995). It also seems that the more times a firm
participates in the PROPYME program, the more its probability of exporting increases,
which would indicate that innovation activities financed by this program seem to help
beneficiary firms to improve the probability that they will succeed in placing their
products in international markets. The coefficient associated with the dosage of the
treatment variable (D_dosage) is positive and significant (0.0256).
When the propensity score matching and the fixed-effects approaches are used
together to estimate the impact of PROPYME on exports of beneficiary firms, the
results obtained for the treatment variable (D) and D_timing are similar to those
obtained when the fixed-effects approach alone is used. However, these new results are
stronger than the ones shown in Table VIII.
Thus, as shown in Table IX, the coefficients associated with these two treatment
variables (D and D_timing) are positive and significant (0.0960 and 0.0714,
respectively), confirming the importance of the participation of SMEs in the
PROPYME program in improving their export probabilities. On the other hand,
the coefficient associated with D_dosage is not significant. A similar result was also
found for lagged treatment variables.
In short, it may be concluded that participation in PROPYME increases the
exporting probability more than nine percentage points on average for beneficiary
firms with respect to those in the control group.
Finally, as shown in the last column of Table IX, the parallel pre-treatment trends
assumption is valid since all of the coefficients associated with pre-treatment variables
are not significant. This last result means that the use of fixed-effects with PSM is a
valid method of estimation of the impact of PROPYME on the exports probabilities of
beneficiary firms.
Conclusions
This study has attempted to estimate the impact of one important productive
development program in Costa Rica: PROPYME. Impacts have been estimated
assuming that beneficiary firms are trying to maximize their profits and that
PROPYME aims to increase these firms’ productivity. The impact was estimated based
on three performance variables: real average wages, labor demand, and the probability
of exporting. The fixed-effects and propensity score matching approaches were used to
control for selection biases and achieve a better comparison between beneficiary and
control group firms in impact estimations. A test for parallel pre-treatment trends was
undertaken as a robustness check for using a fixed-effects approach.
The PROPYME program was found to have positive and significant impacts on
employment and the probability of exporting of beneficiary firms, but not on the real
average wages of the employees of these firms. Among treated firms, labor demand
was found to be about 19 percent higher than among untreated firms. The exporting
probability of treated firms was found to be about 9.6 percentage points higher than
that of untreated firms. These impacts were observed for up to two years after the firm
participated for the first time in the program (in the case of exports). Similarly, the
amount of time elapsed since the first treatment, as well as the number of times that an
SME participated in the program, was found to have a positive impact on labor demand
and on the probabilities of exporting of beneficiary firms.
These results are encouraging, considering that PROPYME during the period
analyzed suffered from significant weaknesses. These included a lack of flexibility in














































program throughout the whole year, and a lack of adequate institutional coordination
to provide beneficiary firms with other financial and non-financial services that would
have contributed to better performance and greater chances for success. Recent efforts
by Costa Rican authorities to improve the operations may contribute to maintaining
and increasing the impact of PROPYME in the future.
Our paper contributes to the existing knowledge on the subject from various
perspectives. It adds to the few rigorous impact evaluation studies for financing
programs to promote investments in R&D, stimulate development and introduction of
new products and production processes in developing countries.
We provide evidence of positive impacts on longer-term improvements in firm
performance (employment) and intermediate outcomes (the probability of exporting).
We coincide with Benavente et al. (2007) who found improvements in firm performance
for a program for technology transfer and development and R&D support in Chile
(National Productivity and Technology Development Fund, FONTEC). However,
our results differ with De Negri et al. (2006) who found no impacts on employment
for R&D subsidy programs and technology development in Brazil (National
Technological Development Support Program, ADTEN) and with Tan (2010) who
found no significant treatment effects for the use of credit and loans programs
alone in Chile.
In sum, the findings suggest that policies aimed at overcoming the weaknesses of
PROPYME are important to obtain higher employment opportunities and exports by
Costa Rican SMEs.
Notes
1. The RU may belong to either a public or private university in Costa Rica or abroad, as well as
a private research unit independent of any university (for instance, non-governmental
organizations or the RU of a private firm).
2. For businesses that present their application without the support of a research unit, this time
period is extended to 45 days.
3. Matching is a procedure by which firms that have characteristics similar to those in the
treatment group (such as years of operation of the firm, economic sector, geographic location
and number of employees) are randomly selected for the control group, according to
variables that may have an effect on incentives to participate in the program and on firm
performance, both before and after the intervention.
4. Matching or propensity score matching (PSM) is one of the most common methods used in
sophisticated and robust impact evaluations, as seen in the most recent case studies
for some Latin American countries (López and Tan, 2010). See also Bernal and Peña (2011,
Chapter 6), for a detailed description of this procedure and a clear application to
empirical cases.
5. See Appendixes 1 and 2 from Monge-González and Rodríguez-Álvarez (2013).
6. In the case of Equation (2) due to endogeneity problems with (w-p) as co-variable, what we
estimated was a reduced form of the full equation derived from a profit maximization
procedure.
7. We prefer this specification instead of a probit or logit model since we would like to use the
fixed-effects method to control for non-observable attributes which are considered to be fixed
over time and which may have an effect on a firm’s decision to receive funds from PROPYME
















































8. That is, firms in the treatment group which are above the maximum observed in the control
group are eliminated, while those firms in the control group which are below the minimum
observation of the treatment group are also eliminated.
9. According to the classification of the Costa Rican Ministry of Economy, Industry, and
Commerce (MEIC), in which micro-businesses are those with five or fewer employees, small-
sized businesses are those that have between 6 and 30 employees, and medium-sized
businesses are those which have between 31 and 100 employees.
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